Influence
April 17, 2020

Regenstrief public health expert provides expertise on tracking COVID-19

Brian Dixon, PhD, MPA, director of public health informatics at Regenstrief Institute and Indiana University Richard M. Fairbanks School of Public Health at IUPUI, has provided perspective on tracking cases of COVID-19 to Indiana and national media.

In interviews with Politico, Dr. Dixon spoke about how the United States healthcare system’s data sharing infrastructure could hinder case tracking and provided perspective on the reporting of racial and ethnic characteristics of COVID-19 patients.

Coronavirus adds new stress to antiquated health record-keeping

Health professionals warn of ‘explosion’ of coronavirus cases in minority communities

Dr. Dixon also spoke to the IndyStar about how Indianapolis compares among other Midwestern cities and the role of testing in understanding the virus outbreak.

Health experts are calling Indiana an emerging coronavirus hot spot. But how bad is it?

Supplies still limit coronavirus testing, which could give incomplete picture of outbreak

Related News

Kathleen Unroe, M.D.

Barriers to Discharge for Nursing Home Residents With Serious Mental Illness

Published in the JAMA Network Open. Here is a link to the article. Regenstrief Institute authors: Kathleen T. Unroe,

Validation of a MIND diet screener in older adults

Published in Alzheimer’s & Dementia Journal. Here is a link to the article. Regenstrief Institute author: Daniel O. Clark,

Fairbanks, Lilly, Regenstrief and Indiana employers collaborate to study obesity medications’ impact

Fairbanks, Lilly, Regenstrief and Indiana employers collaborate to study obesity medications’ impact

INDIANAPOLIS — Researchers from the Fairbanks School of Public Health at Indiana University Indianapolis have launched a first-of-its-kind study

Music for the brain: Study tests the effect of slow-tempo relaxing music to address delirium in critically ill older adults

Music for the brain: Study tests the effect of slow-tempo relaxing music to address delirium in critically ill older adults

Findings support longer-duration or targeted approaches A multi-center randomized controlled trial with critically ill adults aged 50 years and